The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
5 rings ,
What is positive is that Avion and Immupharma have agreed on the clinical way forward . What could have been excellent is that we could have been told that Avion are funding this …
The only financial comment was this ..
´It is also expected to be less costly overall´
Why tell us this , and only this ?
If Avion was footing the full bill , do you think we would be concerned about the cost ??
Anyway , let’s wait for further details on the funding side .
Biffbaffboff,
Avion agreed to fund a P3 trial upto $25 million …
We are now in a P2 trial so one could assume that Avion are going to fund this or not …
Written clarification on this point is a minimum expectation, imo
Maidit308,
After many months of discussions between Avion and Immupharma, one would expect more than this morning’s RNS , imo
No mention of funding is extremely disappointing and highlights the lack of genuine communication with shareholders, imo
Well we got some kind of update but many questions remain unanswered, imo
Back to P2 to begin with so who is fronting the costs ?
Whilst this may be quicker, with a starting date sometime in H2 , we are many years away from a P3 readout …
Let’s see how the market responds but this RNS is far from being optimal , imo
Good to see that the cash runway has been extended In a period where raising money is quite difficult.
Shows confidence and Faron is now in a stronger position to negotiate with Big Pharma , imo
Let’s see what happens in the next few months
So far , so good, EasyP
What goes around comes around… just a matter of time and patience ..imo
Clever Trevor …
Some call him a criminal others just are galled by his lack of morals …
One way or the other , he has quite a few tricks up his sleeve ..
As for here, I think we are ready for another leg up …
Wait and see
Looks like the US funds are placing a lot of money in Europe at the moment …
Even the dog shares are well up in 2023 so far which means a lot of money is being invested in the whole sector as very undervalued since 2022